Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Kiran Mazumdar-Shaw...

    Kiran Mazumdar-Shaw backs move to have separate pharma ministry

    Written by savita thakur thakur Published On 2016-02-29T17:49:21+05:30  |  Updated On 29 Feb 2016 5:49 PM IST
    Kiran Mazumdar-Shaw backs move to have separate pharma ministry
    Hyderabad: Leading industrialist Kiran Mazumdar-Shaw has backed government's proposal to establish a separate ministry for pharma, expressing hope that it would end the current confusion and chaos in the sector due to multi-ministerial control.

    "I think it will, because it's too confused right now. The whole sector is being sort of under the purview of multi- ministerial control. So, I think that is causing a lot of chaos", the chief of Biocon, the country's biggest biotech company told PTI.

    Union Fertilisers Minister HN Ananth Kumar in December had said that there would be a separate ministry for pharma and medical devices sector in the next one year.

    Mazumdar-Shaw, also Chairperson of the Board of Governors at IIM, Bangalore made out a strong case for adequately staffing the drug control administration.

    "Our regulatory standards are pretty high. It's just that they don't have enough people to invigilate. Today, the Drugs Controller is very poorly staffed, and he needs more people, he has been asking for more people. If you don't have more people, how will you carry out all the audits?

    "And then it's also a state subject, not Centre either. So, there are some states where quality standards are high, some states where it is low. So, it's a bit of mixed bag", she said.

    On perception issue of Indian generic industry not being quality compliant, Mazumdar-Shaw said: "Please understand, quality is a big issue, compliant is a big issue, and India has to build credibility in that front. The only way to deal with perception is to build credibility".

    Mazumdar-Shaw further said India's pharmacy colleges need to revamp curricula and also invest in infrastructure and leverage the power of internet to offer best of education standards.
    Ananth KumarBioconKiran MazumdarKiran Mazumdar Shawpharma ministrypharma newspharma news india
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok